GeneGrafts

Cell Therapy for Modulating Excitable Tissues

Health Tech & Life Sciences
Non Active, Nov 2018 ceased to operate
Seed Haifa, Israel Founded 2003
LinkedIn
Last updated 2026-06-18
Total raised
$800K
Last: 2003-12
Stage
Seed
Founded
2003
Headcount
1-10
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

GeneGrafts Ltd is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of the brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias. Thetechnology platform is based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of the target organ are modulated in a predetermined way.

Funding history · 1 round · $800K total

2003-12
Undisclosed
SCP Vitalife

Q&A

What is GeneGrafts' primary focus?
GeneGrafts is a biotechnology company focused on developing proprietary cell therapy technology for modulating excitable tissues, such as those of the brain or heart.
What diseases does GeneGrafts' technology aim to treat?
GeneGrafts' technology aims to treat various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.
How does GeneGrafts' cell therapy platform work?
The technology platform is based on transplanting cell grafts, isolated from the patient's own body, which define ion channels. These grafted cells integrate functionally and structurally with the target organ, modulating its electrical properties in a predetermined way.
When was GeneGrafts founded?
GeneGrafts was founded in November 2003.
What is the current status of GeneGrafts?
GeneGrafts is currently inactive and ceased to operate in November 2018.
How much funding has GeneGrafts raised in total?
GeneGrafts has raised a total of $800,000 USD.
Which investor participated in GeneGrafts' funding round?
SCP Vitalife participated in GeneGrafts' funding round in December 2003.
What is GeneGrafts' employee count?
GeneGrafts has an employee count in the 1-10 range.
Where is GeneGrafts headquartered?
GeneGrafts is headquartered in Haifa, Israel.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cardiologyparkinsonbiotechnologymedical-technologieshospitalsneurologycell-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)